Clinical Trial 42503


Upland, CA 91786

Study Summary:

A phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of bimekizumab in subjects with activate ankylosing spondylitis.

Qualified Participants Must:

• Subject is male or female at least 18 years of age
• Including documented radiologic evidence
• Inflammatory back pain for at least 3 months prior to screening visit
• Age at symptoms onset prior to age 45
• Subjects must have at least 1 of the following: Inadequate responce to nsaids therapy, or intolerance to administrationof at least 1 nsaid, or contraindiction to nsaid therapy

Qualified Participants May Receive:

Subjects that qualify and are enrolled into the study will receive the following: doctor evaluation, blood work results, $40.00 per visit completed.

Study is Available At:

Inland Rheumatology Clinical Trials, Inc
1238 E. Arrow Hwy
Upland, CA 91786
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.